未找到相关数据
A randomized, multicenter phase III study of lobaplatin/etoposide versus cisplatin/etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer and circulating tumor cells (CTCs) as an exploratory biomarker
被引：3
作者：
Cheng, Ying
Fan, Yun
Liu, Xiaoqing
Liu, Yunpeng
Liu, Jiwei
Wang, Dong
Yu, Yan
Qin, Shukui
Liu, Wei
Huang, Cheng
Zhang, Helong
Liang, Jun
Shi, Jianhua
Sheng, Lijun
机构：
[1] Jilin Prov Canc Hosp JPCH, Changchun, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] 307 Hosp Acad Mil Med Sci, Ctr Canc, Beijing, Peoples R China
[4] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China
[5] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China
[6] Third Mil Med Univ Peoples Liberat Army, Affiliated Hosp 3, Chongqing, Peoples R China
[7] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[8] Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Peoples R China
[9] Hebei Tumor Hosp, Shijiazhuang, Peoples R China
[10] Fujian Prov Tumor Hosp, Fuzhou, Peoples R China
[11] 4th Mil Med Univ, Tangdu Hosp, Xian, Peoples R China
[12] Qingdao Univ, Affiliated Hosp, Coll Med, Qingdao 266071, Peoples R China
[13] Linyi Tumor Hosp, Linyi, Peoples R China
[14] Shandong Canc Hosp, Jinan, Peoples R China
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7595
引用
收藏
页数：1
相关论文